‘Blood on your hands’ WHO official says
If rich nations think the pandemic is over, they should help lower-income countries reach that point too, a senior World Health Organization (WHO) official.
Geneva, The Gulf Observer: If rich nations think the pandemic is over, they should help lower-income countries reach that point too, a senior World Health Organization (WHO) official told media. He said ‘Blood on your hands’ if we step back on tackling COVID.
In an interview, WHO senior adviser Bruce Aylward warned that richer nations must not step back from tackling COVID-19 as a global problem now, ahead of future potential waves of infection.
In the last few weeks, WHO Director-General Tedros Adhanom Ghebreyesus said the end of the pandemic was in sight, and U.S. President Joe Biden said the pandemic “is over.”
“When I hear them say, ‘Well, we’re so comfortable here,’ it’s like, ‘Great, now you can really help us get the rest of the world done’,” said Aylward.
Aylward said that the group he coordinates, which focuses on equitable access to COVID-19 vaccines, treatments and tests worldwide, is not yet ready to move out of the emergency phase of tackling the pandemic and that countries need to be ready and have treatments in place for any further waves of infection.
“If you go to sleep right now and this wave hits us in three months God, blood on your hands,” he said.
U.S. has good access to all COVID-19 tools
Aylward said Biden had a point domestically, as the U.S. has good access to all COVID-19 tools. It has also not cut its global commitment to fighting COVID-19, he added.
Aylward coordinates the ACT-Accelerator, a partnership between the WHO and other global health bodies to help poorer countries access COVID-19 tools. The effort, which includes the vaccine-focused COVAX, has reached billions of people worldwide but has faced criticism for not acting quickly enough. There had been some speculation that the effort may wind up this autumn, but Aylward said it was simply changing its focus as the pandemic changes.
Over the next six months, the partnership will focus on delivering vaccines to the roughly one quarter of the world’s healthcare workers and elderly who have still not had a shot, as well as on improving access to test-and-treat, particularly with Pfizer’s Paxlovid, he said.
It will also look to the future as COVID-19 is “here to stay” and unless systems are put in place, support will collapse once other industrialized nations also think the pandemic is over, Aylward warned.
The initiative already has an $11 billion gap in its budget, with most of its available $5.7 billion in funding pledged towards vaccines rather than tests or treatments.
